Events & Presentations
| Date | Event Details | Remind Me |
|---|---|---|
|
Feb 12, 2020
|
Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
|
|
|
Feb 19, 2020
|
Publication of the Annual Report for 2019
|
|
|
Mar 26, 2020
|
Annual General Meeting 2020
|
|
|
May 6, 2020
|
Publication of the Interim Report for the first quarter 2020 (after 5:00 PM CET)
|
|
|
Aug 12, 2020
|
Publication of the Interim Report for the first half 2020 (after 5:00 PM CET)
|
|
|
Nov 4, 2020
|
Publication of the Interim Report for the first nine months 2020 (after 5:00 PM CET)
|
| Date | Event Details | |
|---|---|---|
|
Dec 9, 2019
8:00 PM EST |
2019 R&D Update and ASH Data Review
|
|
|
Nov 8, 2019
4:30 PM CET |
Interactive Q&A Session with Genmab’s CEO
|
|
|
Nov 6, 2019
6:00 PM CET |
First Nine Months of 2019 Financial Results Conference Call
|
|
|
Nov 6, 2019
|
Publication of the Interim Report for the first nine months 2019 (after 5:00 PM CET)
|
|
|
Aug 20, 2019
4:30 PM CEST |
Interactive Q&A Session with Genmab's CEO
|
|
|
Aug 14, 2019
6:00 PM CEST |
First Half 2019 Financial Results Conference Call
|
|
|
Aug 14, 2019
|
Publication of the Interim Report for the first half 2019 (after 5:00 PM CEST)
|
|
|
Jun 13 - Jun 16, 2019
|
24th European Hematology Association Annual Congress, Amsterdam, the Netherlands
|
|
|
May 31 - Jun 4, 2019
|
American Society of Clinical Oncology Annual Meeting, Chicago, IL, US
|
|
|
May 13, 2019
3:00 PM CEST |
Interactive Q&A Session with Genmab's Senior Director, Investor Relations
|
|
|
May 8, 2019
6:00 PM CEST |
First Quarter 2019 Financial Results Conference Call
|
|
|
May 8, 2019
5:00 PM CEST |
Publication of the Interim Report for the first quarter 2019
|
|
|
Mar 29, 2019
|
Annual General Meeting 2019
|
|
|
Mar 4, 2019
4:00 PM CET |
Interactive Q&A Session with Genmab's CEO
|
|
|
Feb 20, 2019
6:00 PM CET |
2018 Full Year Financial Results Conference Call
|
|
|
Feb 20, 2019
5:00 PM CET |
Publication of the Annual Report for 2018
|
|
|
Feb 14, 2019
|
Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
|
|
|
Jan 9, 2019
3:30 PM PST |
37th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US
|
|
|
Dec 3, 2018
8:00 PM PST |
Genmab's 2018 ASH Data Review
Genmab 2018 ASH Data Review 7.3 MB
Genmab will hold a brief R&D Update focused on key product data that was presented during the ASH Annual Meeting. The event will be webcast live. |
|
|
Dec 1 - Dec 4, 2018
|
American Society of Hematology Annual Meeting, San Diego, CA, US
|
|
|
Nov 21, 2018
3:00 PM CET |
Interactive Q&A Session with Genmab's CEO
|
|
|
Nov 15, 2018
|
Jefferies European Healthcare Conference, London, UK
|
|
|
Nov 14, 2018
6:00 PM CET |
First Nine Months 2018 Conference Call
|
|
|
Nov 14, 2018
5:00 PM CET |
Publication of the Interim Report for the first nine months 2018
|
|
|
Sep 26, 2018 from 2:00 PM to 5:30 PM CEST
|
Genmab's Capital Markets Day, Utrecht, The Netherlands
|
|
|
Sep 12, 2018 from 2:15 PM to 2:45 PM EDT
|
Morgan Stanley Global Healthcare Conference, New York, US
|
|
|
Sep 12 - Sep 14, 2018
|
Bank of America Merrill Lynch Global Healthcare Conference 2018, London, UK
|
|
|
Aug 9, 2018
3:00 PM CEST |
Interactive Q&A Session with Genmab's CEO
|
|
|
Aug 8, 2018
6:00 PM CEST |
First Half 2018 Conference Call
|
|
|
Aug 8, 2018
5:00 PM CEST |
Publication of the Interim Report for the first half 2018
|
|
|
Jun 19 - Jun 20, 2018
|
Citi 2018 European Healthcare Conference, London, UK
|
|
|
Jun 14 - Jun 17, 2018
|
23rd Congress of EHA, Stockholm, Sweden
Please see our download library for links to abstracts.
|
|
|
Jun 12, 2018
4:00 PM PDT |
Goldman Sachs 39th Annual Global Healthcare Conference, Rancho Palos Verdes, CA, US
Genmab President & CEO, Jan van de Winkel, Ph.D., will present a company update at the Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, California at 4:00 PM PDT on June 12, 2018 (1:00 AM CEST on June 13, 2018).
|
|
|
Jun 1 - Jun 5, 2018
|
ASCO Annual Meeting, Chicago, IL, US
Please see our download library for links to abstracts.
|
|
|
May 21 - May 23, 2018
|
UBS Global Healthcare Conference, New York, NY, US
|
|
|
May 9, 2018
5:00 PM CEST |
Interactive Q&A Session with Genmab's CEO
|
|
|
May 9, 2018
|
Deutsche Bank's 43rd Annual Healthcare Conference, Boston, MA, US
|
|
|
May 8, 2018
6:00 PM CEST |
First Quarter 2018 Conference Call
|
|
|
Apr 18, 2018
|
Kempen Life Sciences Conference, Amsterdam, The Netherlands
|
|
|
Apr 10, 2018
|
Annual General Meeting 2018
|
|
|
Feb 27, 2018
|
Credit Suisse Healthcare Conference, London, UK
|
|
|
Feb 26, 2018
|
Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
|
|
|
Feb 22, 2018
4:00 PM CET |
Interactive Q&A Session with Genmab's CEO
|
|
|
Feb 21, 2018
5:00 PM CET |
Publication of the Annual Report for 2017
|
|
|
Jan 10, 2018
2:00 PM CET |
36th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US
CEO, Jan van de Winkel, Ph.D., will present a company update at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco at 2:00 PM PST on January 10, 2018 (11:00 PM CET).
|